Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7730550

Concept 2017-03-01 to
2017-11-30
2016-03-01 to
2016-11-30
Consolidated statement of income
Statement of income
Net sales
109,553,000,000 JPY
109,729,000,000 JPY
Ordinary income
Other operating income
Share of profit of entities accounted for using equity method
JPY
55,000,000 JPY
Cost of sales
40,267,000,000 JPY
38,778,000,000 JPY
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
280,000,000 JPY
JPY
Operating expenses
Selling, general and administrative expenses
48,598,000,000 JPY
48,955,000,000 JPY
Operating expenses
Gross profit (loss)
69,285,000,000 JPY
70,951,000,000 JPY
Operating profit (loss)
20,687,000,000 JPY
21,995,000,000 JPY
Net sales
Ordinary profit (loss)
22,043,000,000 JPY
22,885,000,000 JPY
Extraordinary income
487,000,000 JPY
4,198,000,000 JPY
Gain on disposal of non-current assets
0 JPY
JPY
Non-operating income
1,718,000,000 JPY
1,146,000,000 JPY
Dividend income
501,000,000 JPY
467,000,000 JPY
Interest income
302,000,000 JPY
169,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating income
Other
328,000,000 JPY
425,000,000 JPY
Extraordinary losses
6,000,000 JPY
52,000,000 JPY
Loss on disposal of non-current assets
6,000,000 JPY
52,000,000 JPY
Non-operating expenses
Interest expenses
25,000,000 JPY
29,000,000 JPY
Other
19,000,000 JPY
23,000,000 JPY
Non-operating expenses
361,000,000 JPY
256,000,000 JPY
Profit (loss) before income taxes
22,524,000,000 JPY
27,031,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
487,000,000 JPY
0 JPY
Extraordinary losses
Income taxes
6,478,000,000 JPY
8,551,000,000 JPY
Profit (loss)
16,046,000,000 JPY
18,480,000,000 JPY
Profit (loss) attributable to non-controlling interests
206,000,000 JPY
139,000,000 JPY
Profit (loss) attributable to owners of parent
15,840,000,000 JPY
18,340,000,000 JPY
Profit attributable to
Other comprehensive income
Valuation difference on available-for-sale securities
4,873,000,000 JPY
203,000,000 JPY
Foreign currency translation adjustment
-1,876,000,000 JPY
-8,950,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
44,000,000 JPY
-57,000,000 JPY
Remeasurements of defined benefit plans, net of tax
197,000,000 JPY
300,000,000 JPY
Other comprehensive income
3,239,000,000 JPY
-8,418,000,000 JPY
Comprehensive income
19,286,000,000 JPY
10,061,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
19,098,000,000 JPY
9,962,000,000 JPY
Comprehensive income attributable to non-controlling interests
187,000,000 JPY
99,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.